Fidelispharm s. r. o.Active

IČO 54500745limited liability company (s.r.o.)Founded 2022Žilina

Key figures

43 920 €-57,7%
Revenue 2025
+41,7%
Average annual growth 2022–2025
050 k100 k150 k2022202320242025

Key figures

2025

Dividends

calculated
2025

Distributed as dividends 961 €.

Low confidence: the amount exceeds the retained earnings from which dividends can be distributed — probably a merger, an opening balance adjustment or an error in the financial statements.

History
2025 ~961 €
20240 €
20230 €
Balance sheet structure
Current assetsFixed assetsLiabilitiesEquity
020 k40 k20212022202320242025
Summary of annual reports2021–2025
20212022202320242025
Revenue (net turnover)—15 44671 733103 89843 920
Profit for the reporting year—-17 22010 5664 236-10 636
Retained earnings of previous periods00-17 221-6 655-3 380
Total assets5 0009 15033 96534 9716 083
Total liabilities021 37035 62032 39015 099
Total equity5 000-12 220-1 6552 581-9 016
Calculated dividends——00961

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Documents in the Register of Financial Statements12

Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).

Similar companies

Summary: Fidelispharm s. r. o.

Overview

Fidelispharm s. r. o. (IČO 54500745) is a limited liability company (s.r.o.). The company was incorporated in 2022 and has existed for 4 years. Registered office according to the register: Žilina. Main activity according to the Statistical Office: výroba lekárskych a dentálnych nástrojov a potrieb (SK NACE 3250). Size category by number of employees: 1 employee.

People

The company has one statutory representative. According to the register, the company has one shareholder. The registered capital is 5 000 €.

Financial results

Revenue for 2025 was 43 920 €, down 57,7 % on the previous year (103 898 €). From 2022 to 2025, revenue grew by an average of 41,7 % per year. 2025 ended with a loss of 10 636 €. The company was profitable in 2 of the 4 reported years. Personnel costs for 2025 were 3 934 €.

Points to note

Equity was negative at the end of 2025 (-9 016 €).

Sources and freshness

Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 7. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.

Fidelispharm s. r. o. – IČO 54500745 — icoprofil.sk